Adeno-Associated Viral Vector-Mediated Gene Transfer of Human Blood Coagulation Factor IX Into Mouse Liver
Data up to Jan 2025
Total Citations Per Year
Abstract
References (41)
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
1994 • 1,032 citations
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
1996 • 902 citations
Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors
1996 • 747 citations
Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression
1989 • 741 citations
Recombinant adeno-associated virus for muscle directed gene therapy
1997 • 656 citations
MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses
1994 • 619 citations
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
1996 • 608 citations
Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.
1995 • 599 citations
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
1997 • 588 citations
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
1996 • 542 citations
Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.
1993 • 485 citations
Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
1997 • 473 citations
Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
1996 • 383 citations
The Liver: Biology and Pathology
1989 • 348 citations
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice
1993 • 345 citations
In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient Dogs
1993 • 305 citations
Isolation and Characterization of the Human Chromosomal Gene for Polypeptide Chain Elongation Factor-1α
1989 • 277 citations
Adeno-associated virus vectors preferentially transduce cells in S phase.
1994 • 272 citations
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.
1994 • 255 citations
Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes.
1992 • 248 citations
Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors
1997 • 245 citations
DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors
1994 • 227 citations
DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors.
1995 • 220 citations
Effect of the E4 region on the persistence of transgene expression from adenovirus vectors
1997 • 195 citations
Hepatic Gene Therapy: Persistent Expression of Human α1-Antitrypsin in Mice after Direct Gene Delivery In Vivo
1992 • 178 citations
Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B
1989 • 177 citations
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice
1996 • 169 citations
Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
1996 • 143 citations
Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells
1995 • 139 citations
Successful expression of human factor IX following repeat administration of adenoviral vector in mice.
1996 • 125 citations
Molecular Basis of Thrombosis and Hemostasis
1996 • 119 citations
Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B.
1991 • 116 citations
Human hepatoma cells secrete single chain factor X, prothrombin, and antithrombin III
1984 • 97 citations
A Novel Adenovirus—Adeno-Associated Virus Hybrid Vector That Displays Efficient Rescue and Delivery of the AAV Genome
1996 • 92 citations
Role of Intron I in Expression of the Human Factor IX Gene
1995 • 86 citations
Persistent Systemic Production of Human Factor IX in Mice by Skeletal Myoblast-Mediated Gene Transfer: Feasibility of Repeat Application to Obtain Therapeutic Levels
1997 • 44 citations
Current therapeutic relevance of liver gene transfer Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkhous KM, Woo SLC. In vivo gene therapy of hemophilia B: sustained partial correction on factor IX-deficient dogs. Science 1993;262:117?119
1994 • 35 citations
The A2L intermediate gene product is required for in vitro transcription from a vaccinia virus late promoter
1996 • 19 citations
AAV vectors can be efficiently produced without helper virus
1995 • 12 citations
[1] Adeno-associated virus: Integrating vectors for human gene therapy
1995 • 6 citations
A New Form of Strange Matter And New Hope for Finding It
1993 • 2 citations